Categories
Report Researchers

Researchers report first instance of COVID-19 Tripping recurrent blood clots in arms

Credit: Pixabay/CC0 Public Domain Researchers at Rutgers Robert Wood Johnson Medical School are reporting the first instance of COVID-19 triggering a rare recurrence of potentially serious blood clots in people’s arms. The discovery, published in the journal Viruses, improves the understanding of how inflammation caused by COVID-19 can lead to upper extremity blood clots and…

covid
Charge: Pixabay/CC0 Public Domain

Researchers at Rutgers Robert Wood Johnson Medical School are reporting the very first example of COVID-19 tripping a rare recurrence of potentially serious blood clots in people’s arms.

The discovery, published in the journal Viruses, improves the understanding of how inflammation caused by COVID- D 19 can lead to upper extremity and the best way to treat them. The case study is part of a bigger Rutgers study of 1,000 hospitalized patients diagnosed with COVID-19 who were admitted and discharged between March and May 2020.

While there have been reports of lower extremity after COVID-19, this is the first research where COVID-19 triggered a recurrence in the upper arm of an active 85-year-old guy who had a prior diagnosis of upper extremity clots.

“The patient presented to his primary care physician with complaints of swelling in his left arm and was sent to the hospital for further management where he was diagnosed with an upper arm blood clot and an asymptomatic COVID-19 infection,” said Payal Parikh, an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, who led the research along with Martin Blaser, manager of the Center for Advanced Biotechnology and Medicine and a professor at Rutgers Robert Wood Johnson Medical School. “While his were not diminished, he was hospitalized for the management of the upper extremity deep vein blood clot. Often, blood clots are preceded by exacerbated by immobility, and rarely do they occur in patients who are otherwise healthy and active at baseline.”

Most cases of deep vein thrombosis occur in the legs. Just about 10 percent of blood clots occur in the arms and of these cases only 9 percent recur.

“This is of concern since in 30 percent of these patients, the blood can travel to the lung and be possibly fatal,” said Parikh. “Other disabling complications include persistent swelling, pain and arm fatigue.”

The study suggests that clinicians should consider testing for deep vein thrombosis and COVID-19 in patients who present with complaints of unexplained swelling. People who test positive for COVID-19 should seek when they’ve declining oxygen levels, shortness of breath and some other unexplained swelling.

“If you have been previously diagnosed with deep vein thrombosis or have chronic medical illness that predisposes you to blood clots, you have a higher risk for recurrence of a deep vein thrombus in the setting of a COVID-19 infection and thus, should be vigilant,” sa

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *